EFFICACY AND SAFETY OF TOFACITINIB AFTER FAILURE OF ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A US-BASED PROPENSITY MATCHED COHORT STUDY

被引:0
作者
Kochhar, Gursimran S.
Desai, Aakash
Dulai, Parambir S.
Cross, Raymond K.
Farraye, Francis A.
Regueiro, Miguel D.
El-Hachem, Sandra
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1711
引用
收藏
页码:S646 / S647
页数:2
相关论文
共 50 条
  • [31] Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the US
    Desai, Aakash
    Sehgal, Priya
    Khataniar, Himsikhar
    Lewis, James D.
    Farraye, Francis A.
    Lichtenstein, Gary R.
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (07) : 1197 - 1207
  • [32] Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study
    Buisson, A.
    Serrero, M.
    Altwegg, R.
    Guilmoteau, T.
    Bouguen, G.
    Nachury, M.
    Amiot, A.
    Vuitton, L.
    Treton, X.
    Caillo, L.
    Pereira, B.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 707 - 707
  • [33] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study(vol 22, 498, 2022)
    Rayer, Cassandra
    Nachury, Maria
    Bourreille, Arnaud
    Roblin, Xavier
    Peyrin-Biroulet, Laurent
    Viennot, Stephanie
    Flamant, Mathurin
    Laharie, David
    Caron, Benedicte
    Dewitte, Marie
    Siproudhis, Laurent
    Fumery, Mathurin
    Bouguen, Guillaume
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [34] Tofacitinib for acute severe ulcerative colitis: Efficacy and safety in a tertiary center's biologic-failure cohort
    Mithanthaya, A.
    Abu-Rgeef, R.
    Picardo, S.
    Venugopal, K.
    So, K.
    Menon, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 124 - 125
  • [35] SAFETY AND EFFICACY OF ANTI-TNF THERAPY IN OLDER PATIENTS WITH ULCERATIVE COLITIS: A PATIENT-LEVEL POOLED ANALYSIS OF RCT DATA
    Cheng, David
    Cushing, Kelly C.
    Cai, Tianxi
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2019, 156 (06) : S43 - S43
  • [36] REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY
    Buisson, Anthony
    Serrero, Melanie
    Altwegg, Romain
    Guilmoteau, Thomas
    Guillaume, Bouguen
    Nachury, Maria
    Amiot, Aurelien
    Vuitton, Lucine
    Treton, Xavier
    Caillo, Ludovic
    Pereira, Bruno
    Fumery, Mathurin
    GASTROENTEROLOGY, 2023, 164 (06) : S4 - S4
  • [37] Comparative efficacy of infliximab and vedolizumab after failure of a first anti-TNF in patients with ulcerative colitis: a double-blind randomized controlled trial (EFFICACI)
    Bouguen, G.
    Nachury, M.
    Nancey, S.
    Bouhnik, Y.
    Bourreille, A.
    Altwegg, R.
    Vuitton, L.
    Buisson, A.
    Viennot, S.
    Laharie, D.
    Fumery, M.
    Gillettta, C.
    Uzzan, M.
    Delobel, J. B.
    Amiot, A.
    Peyrin-Biroulet, L.
    Gornet, J. M.
    Caillo, L.
    Roblin, X.
    Laviolle, B.
    Ahmim, M.
    Tron, C.
    Bendavid, C.
    Le Pabic, E.
    Landemaine, A.
    Hebuterne, X.
    GETAID
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i74 - i74
  • [38] Comparative effectiveness and safety of upadacitinib, tofacitinib, and filgotinib in patients with Ulcerative Colitis: analysis of whole and propensity score-matched data
    Bertin, L.
    Scarabello, D.
    Zingone, F.
    Savarino, E., V
    Barberio, B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1294 - i1295
  • [39] Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Sharara, Ala, I
    Su, Chinyu
    Modesto, Irene
    Mundayat, Rajiv
    Gunay, L. Mert
    Salese, Leonardo
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : 591 - +
  • [40] Treatment Persistence Among Anti-TNF-Experienced Patients With Ulcerative Colitis Switching to Ustekinumab or Cycling to Another Anti-TNF Agent
    Zhdanava, Maryia
    Burbage, Sabree
    Boonmak, Porpong
    Kachroo, Sumesh
    Lefebvre, Patrick
    Shah, Aditi
    Godwin, Bridget
    Pilon, Dominic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S) : S13 - S13